[Antitumor activity of 1-hexylcarbamoyluracil which is carmofur substituted fluorine for hydrogen].
Tokuda
C
C
Institute of Biological Science, Mitsui Pharmaceuticals Inc.
Miyama
Y
Y
Takeda
H
H
Fukui
H
H
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D013274:Stomach Neoplasms / Q000473:pathology; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014498:Uracil / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology
C411622:1-hexylcarbamoyluracil; D000970:Antineoplastic Agents; D014498:Uracil; C017367:carmofur; D005472:Fluorouracil